SEZABY is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Phenobarbital Sodium.
Product ID | 62756-301_6ac5c671-68ab-4347-9cd6-1fd6ef32b069 |
NDC | 62756-301 |
Product Type | Human Prescription Drug |
Proprietary Name | SEZABY |
Generic Name | Phenobarbital Sodium |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-12-25 |
Marketing Category | NDA / |
Application Number | NDA215910 |
Labeler Name | Sun Pharmaceutical Industries, Inc. |
Substance Name | PHENOBARBITAL SODIUM |
Active Ingredient Strength | 100 mg/1 |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2022-12-26 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
62756-301 | SEZABY | phenobarbital sodium |
0641-0476 | Phenobarbital Sodium | Phenobarbital Sodium |
0641-0477 | Phenobarbital Sodium | Phenobarbital Sodium |
14789-127 | Phenobarbital Sodium | Phenobarbital Sodium |
14789-128 | Phenobarbital Sodium | Phenobarbital Sodium |
42494-415 | Phenobarbital Sodium | Phenobarbital Sodium |
42494-416 | Phenobarbital Sodium | Phenobarbital Sodium |
54288-136 | Phenobarbital Sodium | Phenobarbital Sodium |
54288-137 | Phenobarbital Sodium | Phenobarbital Sodium |
63629-1997 | Phenobarbital Sodium | Phenobarbital Sodium |
63629-1998 | Phenobarbital Sodium | Phenobarbital Sodium |
63629-2007 | Phenobarbital Sodium | Phenobarbital Sodium |
63629-2008 | Phenobarbital Sodium | Phenobarbital Sodium |
75834-288 | Phenobarbital Sodium | Phenobarbital Sodium |
75834-289 | Phenobarbital Sodium | Phenobarbital Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SEZABY 97098882 not registered Live/Pending |
Sun Pharma Advanced Research Company Limited 2021-10-29 |